Retrospective outcome analysis of 25 alopecia areata patients treated with simvastatin/ezetimibe

J Am Acad Dermatol. 2019 Sep;81(3):854-857. doi: 10.1016/j.jaad.2019.04.047. Epub 2019 Apr 20.

Authors

Carlos Morillo-Hernandez¹, Jonathan J Lee², Joseph C English 3rd³

Affiliations

¹ University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
³ Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: englishjc@upmc.edu.

PMID: 31015012
DOI: 10.1016/j.jaad.2019.04.047

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Alopecia Areata / drug therapy*
Anticholesteremic Agents / therapeutic use*
Dermatologic Agents / pharmacology
Dermatologic Agents / therapeutic use*
Drug Resistance
Drug Substitution
Drug Therapy, Combination / methods
Ezetimibe, Simvastatin Drug Combination / pharmacology
Ezetimibe, Simvastatin Drug Combination / therapeutic use*
Female
Humans
Male
Methotrexate / pharmacology
Methotrexate / therapeutic use*
Middle Aged
Retrospective Studies
Treatment Outcome
Young Adult

Substances

Anticholesteremic Agents
Dermatologic Agents
Ezetimibe, Simvastatin Drug Combination
Methotrexate